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The pathogenesis of itchy skin diseases including allergic contact dermatitis (ACD) is
complicated and the treatment of chronic itch is a worldwide problem. One traditional
Tibetan medicine, Qingpeng ointment (QP), has been used in treatment of ACD
in China for years. In this study we used HPLC and LC/MS analysis, combined
with a BATMAN-TCM platform, for detailed HPLC fingerprint analysis and network
pharmacology of QP, and investigated the anti-inflammatory and antipruritic activities of
QP on ACD induced by squaric acid dibutylester (SADBE) in mice. The BATMAN-TCM
analysis provided information of effector molecules of the main ingredients of QP, and
possible chronic dermatitis-associated molecules and cell signaling pathways by QP. In
ACD mice, QP treatment suppressed the scratching behavior induced by SADBE in a
dose-dependent manner and inhibited the production of Th1/2 cytokines in serum and
spleen. Also, QP treatment reversed the upregulation of mRNAs levels of itch-related
genes in the skin (TRPV4, TSLP, GRP, and MrgprA3) and DRGs (TRPV1, TRPA1, GRP,
and MrgprA3). Furthermore, QP suppressed the phosphorylation of Erk and p38 in
the skin. In all, our work indicated that QP can significantly attenuate the pathological
alterations of Th1/2 cytokines and itch-related mediators, and inhibit the phosphorylation
of MAPKs to treat the chronic itch.
Keywords: Tibetan medicine, chronic itch, allergic contact dermatitis, MAPK, mice

INTRODUCTION
Chronic itch has been long known not only as a concomitant manifestation of various skin
diseases, such as contact dermatitis, eczema, atopic dermatitis, psoriasis, etc., but also occurs in
systemic, neurological, or psychiatric diseases. So far, medications for chronic itch still can be simply
categorized into topical (emollients and moisturizers, anesthetics, coolants, glucocorticoids, others)
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CXCL10/CXCR3 signaling in sensory neurons may contribute to
the pathogenesis of the chronic itch in this model (Fu et al., 2014).
Most recently we and our collaborators found transient receptor
potential (TRP) channels, TRPV1 and TRPA1-expressing sensory
neurons or TRPV4 in the TRPV4-expressing epithelial and
immune cells in the skin are molecular and cellular basis for
SADBE-induced chronic itch (Feng et al., 2017; Luo et al., 2018).
In order to fully understand the pharmacological functions
of herbal ingredients or components, we also employed a
newly developed bioinformatics analysis tool, BATMAN-TCM
(a Bioinformatics Analysis Tool for Molecular mechanism of
Traditional Chinese Medicine) established by our collaborator.
Unlike the traditional concept of “one drug, one goal,”
BATMAN-TCM tries to seek the key molecules targeted by
the main components of TCM, and discover the biological
networks derived from these molecules (Liu Z. et al., 2016;
Zhang et al., 2017). Meanwhile, the data will be compared
with the molecular targets and signal pathway networks related
to diseases established in the database, and will describe the
complicated mechanisms and potential therapeutic values of the
drug (Liu Z. et al., 2016; Zhang et al., 2017, 2018). Therefore,
this study attempted to introduce BATMANTCM into the
ACD study and investigate the anti-inflammatory activities of
QP on ACD induced by SADBE in mice, especially whether
QP treats the chronic itch, and if it does what the possible
mechanism could be.

and systemic (antihistamines, neuroactive medications,
antidepressants, phototherapy, etc.) forms (Yosipovitch and
Bernhard, 2013; Pereira and Stander, 2017; Hachisuka et al.,
2018; Shevchenko et al., 2018). Due to its heterogeneity, the
causes and pathophysiology of chronic itch are complicated.
The treatment of chronic itch, especially intractable itch, is a
worldwide problem and a great challenge for clinicians.
Complementary and alternative medicine (CAM), including
herbal or botanical therapies, traditional Chinese medicine
(TCM), dietary supplements, etc., is clinically used to treat
intractable skin diseases like psoriasis. A large amount of evidence
indicated those CAM managements could effectively relieve the
symptoms of diseases or their underlying causes, which cannot
be solved by western medicine (Farahnik et al., 2017; Parker
et al., 2017; Svendsen et al., 2017; Na Takuathung et al., 2018).
For example, it is estimated that there are about 10–62% of
patients with psoriasis in the western world seeking the use of
CAM (Farahnik et al., 2017; Svendsen et al., 2017). Consistently
animal experimental studies have also accumulated a wealth of
data demonstrating the effectiveness of the use of CAM in animal
models (Na Takuathung et al., 2018).
Allergic contact dermatitis (ACD) is a skin T cell-mediated
immune response caused by one or more non-toxic allergens
in contact with the skin, and often occurs together with
irritant contact dermatitis significantly affecting the quality
of life (Kostner et al., 2017). Existing treatments for ACD
are still limited to a few traditional methods such as topical
steroids and immunosuppressants, etc., etiologically based and
efficient treatments are still lacking. Over centuries Chinese
medicines have been used in the treatment of ACD, and their
main ingredients and possible molecular mechanisms have been
gradually recognized (Li and Li, 2013; Li et al., 2013, 2018;
Fu et al., 2015). One traditional Tibetan medicine, Qingpeng
ointment (QP), has been used in treatment of ACD in China
for many years. QP contains nine main ingredients including
Oxytropis falcata Bunge, Rheum lhasaense, Aconitum pendulum
Busch, Terminalia chebula Retz (stoned), Terminalia billerica
(Gaertn.) Roxb, Phyllanthus emblica Linn., Styrax tonkinensis
(Pierre) Craib ex Hartw, Tinospora sinensis (Lour.) Merr., and
Synthetic musk (Product Manual, Qizheng Tibetan Medicine Co.,
Ltd., Lanzhou, China). Two previous works reported that QP
exerts anti-inflammation and ameliorates ACD in BALB/c mice
(Li and Li, 2013; Li et al., 2013, 2018; Fu et al., 2015). However,
similar to other TCM experimental studies on ACD they have
some common problems. For example, their ACD model was
established by topical 4-dinitrofluorobenzene (DNFB), a model
that has been used for a long time but still has actual unknown
molecule mechanisms (Li and Li, 2013; Li et al., 2013, 2018;
Fu et al., 2015). Secondly without exception, they all focus on
anti-inflammatory effect and none of them have comprehensively
studied the chronic itch associated with ACD.
Squaric acid dibutylester (SADBE), a small molecule hapten,
is commonly used in the treatment of alopecia areata and
has been used as a popular ACD inducer in mice (Fu et al.,
2014; Feng et al., 2017; Luo et al., 2018). Remarkably in recent
years neuroimmune mechanisms of SADBE-induced chronic
itch were greatly investigated. It was showed that the increased
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MATERIALS AND METHODS
QingPeng Ointment Preparation and
HPLC Analysis
The QP ointment used in this study was purchased from
Tibet Qizheng Tibetan Medicine Co., Ltd. (Lanzhou, China)
and the same batch of drug product was sued for all
animal experiments, LC/MS analysis and BATMAN-TCM Target
Prediction and Analysis. QP ointment contains nine kinds of
herbal components, including O. falcata Bunge, R. lhasaense,
A. pendulum Busch, T. chebula Retz (stoned), T. Billerica
(Gaertn.)Roxb, P. emblica Linn., S. tonkinensis (Pierre) Craib ex
Hartw, T. sinensis (Lour.) Merr., and S. musk, which were mixed
at a weight ratio of 20:10:15:20:20:20:7:30:5.
For identification of the main constituents, the mass spectral
analyses were performed using an Agilent 6540 Q-TOF LC/MS
system (Agilent Technologies, Santa Clara, CA, United States).
The operating conditions for ESI interface were as following:
positive/negative ionization mode; spray voltage, 3.8 kV; gas
temperature, 350◦ C; and the full scan range was from 100 to 1600
m/z. An Agilent 1290 HPLC system equipped with a G1379A
HPLC pump, a G1315B DAD detector and a ZORBAX SB-C18
column (250 × 4.6 mm, 5 µm) was used for the HPLC analysis.
The mobile was consisted of acetonitrile (solvent A) and 5%
methanol aqueous solution (including 0.1% formic acid, solvent
B) and the gradient elution program was as below: 0∼10 min,
100% B; 10∼25 min, 0–5% A, 100∼95% B; 25∼60 min, 5∼10% A,
95∼90% B; 60∼100 min, 10∼20% A, 90∼80% B; 100∼150 min,
20∼70% A, 80∼30% B, 150∼180 min, 70% A, 30% B. The flow
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rate was 1.0 mL/min, and the sample injection volume was 10 µL.
The detection wavelength was set at 284 nm.

recorded by the camera under unmanned conditions for 60 min,
and the number of scratches to the shaved part of the neck
was counted by people blinded to the experimental design. The
treatment group was topically applied to the shaved nape of
the neck with low, medium and high dose QP (0.625, 1.25,
and 2.5 g/kg) twice a day starting from day 0 to day 12, and
once a day on day 13. Diphenhydramine (10 mg/kg i.p.) as the
positive drug was injected into the mice on day 13. The following
scratching behavior was recorded after 30 min at the last QP and
diphenhydramine treatment by observers. The control group was
used same volume of acetone other than 0.5% SADBE/acetone.
The model group mice were applied to the blank substrate (from
Tibet Qizheng Tibetan Medicine Co., Ltd.) at the same time (Feng
et al., 2017; Luo et al., 2018).

BATMAN-TCM Target Prediction and
Analysis
The target prediction method adopted the BATMAN-TCM
platform, which in principle, is a similarity-based method to
predict potential drug–target interactions based on the similarity
of those known TCMs drug–target interactions. Simply, the
combination of QP composition and their corresponding
PubChem ID were an input into BATMAN-TCM software
for network pharmacological analysis to obtain the results
of the “drug-disease” potential target prediction (Liu Z.
et al., 2016; Zhang et al., 2017). The analysis was based on
multiple source database included TCMID database (providing
a giant formula-herb-ingredient association data), DrugBank
(downloaded on July 26, 2015), KEGG (version: July 31, 2014),
TTD (Therapeutic Target Database) (version: 4.3.02), OMIM
(Online Mendelian Inheritance in Man) (downloaded on Mar.
13, 2014), and TTD (version: 4.3.02) (Liu Z. et al., 2016;
Zhang et al., 2017).

Skin Morphology Studies
The skin in midline of the mouse neck was collected and fixed
in 4% paraformaldehyde, routinely dehydrated, embedded in
paraffin, and sectioned. Hematoxylin & eosin (HE) and toluidine
blue staining were performed as previously described (Zhao et al.,
2013). After the stained sections were dehydrated, cleared and
sealed, they were visualized under a microscope, and images were
taken. Image J software was used to measure the relative thickness
of the epidermis from HE staining images and count the number
of mast cells from toluidine blue staining images.

Animals and Drugs
Male C57BL/6 mice were purchased from Beijing Vital River
Laboratory Animal Technology Co., Ltd. (Beijing, China).
Animals were single-caged and housed in a SPF-grade
environment with water and food ad libitum at temperature
(24 ± 2)◦ C, a 12-h/12-h light/dark cycle lighting off at night
(7:00 pm–7:00 am), at least adapted for 1 week before behavior
work. All behavioral tests were videotaped above the observation
boxes, and assessed by observers blinded to the experimental
design. In this study, mice used for behavioral tests were divided
into the blank control group (acetone topically), the model group
(0.5% SADBE/acetone topically), groups of treatment low-dose,
medium-dose and high-dose of QP ointment applied to the
shaved nape of the neck (0.625, 1.25, and 2.5 g/kg), or the positive
drug (Diphenhydramine Hydrochloride, 10 mg/kg, i.p.). In this
study, male mice at 7 weeks old were used for experiments.
All animal experimental procedures followed international
guidelines for care and use of laboratory animals which were
approved by the Animal Ethics Committee of South-central
University for Nationalities. SADBE was purchased from
J&K Scientific Ltd. (Beijing, China). QP was purchased from
Tibet Qizheng Tibetan Medicine Co., Ltd. (Lanzhou, China).
Diphenhydramine hydrochloride was purchased from Shanghai
Yuanye Bio-Technology Co., Ltd. (Shanghai, China).

SDS–PAGE and Western Blotting
The total protein from the mouse midline back neck skin and
cervical Dorsal Root Ganglion (DRG) (C1–C7) were extracted as
according to standard protocols. Simply, a 1% protease inhibitor
(Roche, Switzerland) and a 1% phosphatase inhibitor (Roche,
Switzerland) were added to the protein lysate. By using this
lysate buffer, the mouse tissues were homogenized and sonicated,
then placed on ice for 30 min, and centrifuged (12000 g, 4◦ C,
9 min) to take the supernatants for the next steps. Samples were
denatured in a 20% 5× loading buffer and heated in a boiling
water bath for 8 min. After cooling, the samples were separated
and cryopreservation. Proteins were separated by SDS–PAGE (7
or 10% acrylamide) and blotted onto PVDF membranes. The
membrane was incubated with primary antibodies overnight at
4◦ C, and the primary antibodies involved were anti-P38 (8690S,
1:1000), anti-phospho-P38 (4511S, 1:1000), anti-Erk (4695S,
1:1000), anti-phospho-Erk (4370P, 1:2000), anti-Akt (4691S,
1:1000), anti-phospho-Akt (4060S, 1:2000), anti-Stat3 (12640S,
1:1000), anti-phospho-Stat3 (9145P, 1:2000), anti-IκBα (4812S,
1:1000), anti-phospho-IκBα (2859S, 1:2000) (CST, Danvers,
MA, United States) and anti-Tubulin (Proteintech, Wuhan,
China, 1:10000). Then the membranes were incubated with
the appropriate horseradish peroxidase-conjugated secondary
antibodies for 1 h at room temperature. The following
immunoreactive polypeptides were visualized using ECL (ZETA,
San Francisco, CA, United States) assays, and Tubulin was used
as an internal control.

Mouse Model of ACD and Treatments
The model was mainly established following previous work (Feng
et al., 2017; Luo et al., 2018). The mice were sensitized once per
day for three consecutive days (from day 0 to day 2) by applying
20 µL of 0.5% SADBE/acetone solution topically to the shaved
abdominal skin. 5 days later, 20 µL of 0.5% SADBE/acetone
solution was applied topically to shaved mouse neck skin about
3 × 3 cm region in the midline backs once a day for three
consecutive days. 3 days later, the paw scratching behavior was
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Quantitative RT-PCR
Total RNA was extracted from homogenized DRG neurons or
skin samples using the Trizol reagent (TaKaRa, Japan) according
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on the results of LC/MS. These batch numbers were as follows:
161130 (S1), 170308 (S2), 170812 (S3), 171134 (S4), and 180513
(S5). The retention times of three compounds were 12.03, 57.82,
and 81.41 min, respectively (Figures 1A,B).

to the manufacturer’s instructions. RNA was treated with DNase
I and cDNA was synthesized in vitro using a ThermoScript
RT-PCR reverse transcription kit. Each reaction was performed
in a system containing 10 µL SYBR Mix, 2 µL cDNA, 1 µL
primer mix and 7 µL RNase-free water, using a real-time PCR
system. Relative mRNA expression levels of different target genes
compared to GAPDH or β-Actin were calculated using the
2−11Ct method. The primer sequences (50 to 30 ) involved were
showed in Table 1.

The Visualization of QP
Ingredient-Target-Pathway/Chronic
Dermatitis Association Network
To establish the related target prediction and network/pathway
analysis for QP to treat chronic dermatitis, the current work used
the platform of BATMAN-TCM and obtained the interactive
network diagram of QP-chronic dermatitis (Figure 2). In the
view of the association network, based on QP’s drug targets
and biological pathways, targets of chronic dermatitis diseases
and predicted pathways, the prediction results are divided into
three types of nodes including composition-targets association,
disease-targets association and their overlapping association.
A complete gene names of targets and biological pathways for
QP’s drug and/or chronic dermatitis, see MS Excel worksheets 1
and 2 in Supplementary Table S1.

Measurement of Cytokines
Detection of IgE, Histamine, TNF-α, IFN-γ, IL-1β, IL-4,
IL-5, IL-10, etc., in the spleen and serum of mice using an
ELISA kit according to the manufacturer’s instructions. All
mouse ELISA kits were purchased from Shanghai Jianglin
Biotechnology Co., Ltd.

Statistical Analysis
All data was expressed as the means ± SEM. GraphPad Prism
6 software (San Diego, CA, United States) was used for the
data statistical analysis and graphics. Unpaired t-test was used
to analyze statistical comparisons between two groups. Multiple
comparisons were compared by one-way analysis of variance
(ANOVA) followed by Bonferroni’s post hoc tests. p-value < 0.05
was assumed as statistically significant.

QP Attenuated Scratching Behavior
Induced by SADBE in Mice
Skin allergies and chronic dermatitis have been caused by topical
application of SADBE, a popular ACD inducer in mice (Fu et al.,
2014; Feng et al., 2017; Luo et al., 2018). In this study, we followed
the schematic experimental protocol (Fu et al., 2014; Feng
et al., 2017; Luo et al., 2018) and pretreated mice with SADBE
in the abdomen for 3 days (sensitization) and re-stimulated
after 3 days topically on the neck (challenge), which induced
robust spontaneous scratching behavior in mice (Figure 3A).
Previous analyses indicated that no corticosteroid existed in
QP (Li and Li, 2013; Li et al., 2013) and antihistamines have
been used traditionally in the attenuation of experimental and
clinical pruritus (Yosipovitch and Bernhard, 2013; Mahapatra
et al., 2014; Pereira and Stander, 2017; Hachisuka et al., 2018;
Shevchenko et al., 2018), therefore in this study we used a
classic antihistamine, diphenhydramine, as the positive control
medicine. Similar to previous reports (Fu et al., 2014; Feng et al.,
2017; Luo et al., 2018), compared with the blank control mice,

RESULTS
HPLC Profile of QingPeng Ointment
Using the current LC/MS method, three main compounds of QP
were identified, including gallic acid (1) (Teodoro et al., 2018),
corilagin (2) (Salih et al., 2017), and ellagic acid (3) (BenSaad
et al., 2017) (their structures showed in Supplementary Figure
S1). These compounds are all phenolic acid derivatives and
gallic acid as the main unit. In their mass spectrum, fragment
ions at m/z 465 [M-169]+ in the 2 indicated the existence
of gallic acid unit, and m/z 153, 121 in the 3 indicated the
existence of 3,4-dihydroxybenzoic acid and benzoic acid units
(Supplementary Figure S1). Five batches purchased from Tibet
Qizheng Tibetan Medicine Co., Ltd. were also examined based

TABLE 1 | Primer sequences.
Gene name

Forward (50 -30 )

TRPV1

CCCGGAAGACAGATAGCCTGA

TTCAATGGCAATGTGTAATGCTG

TRPV4

CGCCCGCGTCCTGAG

TCCCCCTCAAACAGATTGGC

TRPA1

GCTGGACTGCTTTGCATCAC

AAGCATTGCAACAGCCTTGG

GRP

CCTAGAAGCTGCTGGGAACC

CCCTTGTCGTTGTCCCTTCA

TSLP

CGCCCTCGACTCGGAC

TTCCAGAAGAGCCATCGCAG

MrgprA3

TCCAGCAAGAGGAATGGGAG

CATTGTCGAGGCTGAGGTGT

IL-4

TCTCGAATGTACCAGGAGCCATATC

AGCACCTTGGAAGCCCTACAGA

IL-5

GCTTCTGCACTTGAGTGTTCTG

CCTCATCGTCTCATTGCTTGTC

IL-10

CAAGGAGCATTTGAATTCCC

GGCCTTGTAGACACCTTGGTC

GAPDH

AAGAGGGATGCTGCCCTTAC

ATGAAGGGGTCGTTGATGGC

β-Actin

GTGACGTTGACATCCGTAAAGA

GTAACAGTCCGCCTAGAAGCAC

Frontiers in Pharmacology | www.frontiersin.org

Reverse (50 -30 )
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FIGURE 1 | HPLC fingerprint analysis of QP ointment. The HPLC chromatographic of QP at 284 nm wavelength was recorded (A). There are at least 3 phenotypic
peaks, which are derived from gallic acid (1), corilagin (2), and ellagic acid (3), respectively. HPLC fingerprint of 5 batches of QP was also presented (B).

SADBE indeed induced robust scratching behaviors (p < 0.0001)
(Figure 3B). All three QP treatments (0.625, 1.25, and 2.5 g/kg)
and the positive drug (diphenhydramine, 10 mg/kg) significantly
decreased the scratching behavior than that in the model
group (p < 0.05). It is worth noting that QP can work in a
dose-dependent manner to suppress the pruritus response in the
ACD model (Figure 3B).

The data indicated, in mice SADBE initiated thickening of skin
and increased infiltration of mast cells, which could not be
significantly inhibited by QP.

QP Inhibited Upregulation of Cytokines
and Itch Molecules in the Skin of SADBE
Mice
In this study we tried to take advantage of the information
from our network pharmacological study (Figure 2 and
Supplementary Table S1) for molecular analysis. Upon the
results of potential effector molecules they provided, we
analyzed the mRNA expression levels of IL-5, IL-10, TRPV4,
TSLP, GRP, and MrgprA3 in the skin from different groups
of mice. The experimental results showed that the mRNA
levels of IL-5, IL-10, TRPV4, TSLP, GRP, and MrgprA3
in the skin of the model group were significantly higher
than those in the blank control group. Compared with the
model group, QP treatments (especially at the high dose
group) can significantly reduce the enhanced IL-5, IL-10,
TRPV4, TSLP, GRP, and MrgprA3 mRNA levels in the
skin of SADBE mice (Figure 5). The positive control drug

Effect of QP on Skin Histological
Changes Induced by SADBE
We next examined the SADBE induced skin lesions and whether
the QP treatments were beneficial to them. From the skin
general appearance observed, compared with the model group,
mice after treated with different doses of QP showed some
signs of reduced skin lesions (Figure 4A). However, from the
results of HE (Figures 4B,C) and toluidine blue (Figures 4D,E)
staining, there was no significant differences after any QP
or diphenhydramine treatment as compared with the model
group, and by the measurement of skin thickness and the
number of mast cells, which have been frequently used as
indicators for the skin inflammation and immune cell infiltration.

Frontiers in Pharmacology | www.frontiersin.org
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FIGURE 2 | QP ingredient-target-pathway/chronic dermatitis association network. Red nodes correspond to the predicted key targets of chronic dermatitis, such as
TLR4, STAT1, STAT3, PRKACA, PSMB8, IL2RG, CD3G, etc. Blue nodes correspond to the key targets of QP ointment, such as IL-8, CXCR4, JUN, IL-1β, IL-17A,
etc., Green nodes represent the key targets associate to both QP and chronic dermatitis, such as IL-4, IL-6, IL-10, TNF, NFκB1, PIK3R3, PIK3CA, EGFR, KIT, ESR1,
NR3C1, etc.

diphenhydramine, was able to significantly decrease that of IL-10,
GRP, and MrgprA3.

group increased significantly. Compared with the model group,
the high-dose QP significantly decreased the expression of p-P38
and p-Erk (Figures 6B,C) in the skin. Detection of the p-Stat3,
p-Akt and p-IκBα expression in the skin of mice revealed that
there was no significant difference in their expression levels
among the groups (Figures 6A,D–F).

QP Inhibited p-P38 and p-Erk Signaling
Augments in the Skin of SADBE Mice
It is well known a number of intracellular kinase cascades
would be activated by inflammatory mediators and participate
in the generation and maintenance of immune responses in
dermatitis (Ayush et al., 2013; Bechara et al., 2017; Oetjen
et al., 2017; Li et al., 2018; Xiao and Xiao, 2018). Considering
the information from our network pharmacological study
(Figure 2 and Supplementary Table S1), expression of several
important protein kinases was detected in the skin of mice
(Figures 6A–F). Compared with the blank control group, the
level of phosphorylated P38 (Figure 6C) in the skin of the model

Frontiers in Pharmacology | www.frontiersin.org

QP Inhibited Upregulation of Cytokines
and Itch Molecules in the DRGs of
SADBE Mice
The DRG is the site where the primary neuronal cells are
clustered and also a critical site for the development itch sensory
information in the periphery (Han et al., 2013; Liu Z. et al., 2016;
Kittaka and Tominaga, 2017; Zhang et al., 2017). Real-time PCR
was used to measure the mRNA levels of TRPV1 (Figure 7A),
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FIGURE 3 | QP reduced the itching caused by allergic contact dermatitis induced by SADBE. (A) A Schematic diagram shows the experimental protocol. 0.5%
SADBE/acetone was topically treated daily 3 times to the mouse abdomen, and re-stimulated topically daily 3 times to the neck back skin after a 5 days’ break.
Spontaneous scratching was videotaped and analyzed afterward. (B) The behavior results of SADBE mice in different controls or after three QP (0.625, 1.25, and
2.5 g/kg), and the positive drug (diphenhydramine, 10 mg/kg). Data was expressed as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗∗ p < 0.0001, compared with
the model group. ++++ p < 0.0001, compared with the blank control group. One-way ANOVA followed by post hoc test (n = 5 each group). The method and criteria
to present and statistically analyze the data in (B) were followed the same in all other work in this paper unless mentioned specifically.

TRPA1 (Figure 7B), GRP (Figure 7C), and MrgprA3 (Figure 7D)
in the DRG of mice. As shown in Figure 7, the levels of TRPV1,
GRP, and MrgprA3 mRNA in the DRG of model group were
significantly higher than those in the blank control group. The
positive drug diphenhydramine was effective in reducing TRPA1
and TRPV1 mRNA levels. Even though the low-dose QP had
no significant effect on the four itch-related genes, however,
compared with that of the model group, TRPV1 and GRP mRNA
levels were significantly reduced by the medium-dose of QP, and
TRPV1, TRPA1, GRP, and MrgprA3 mRNA levels were markedly
reduced by the high-dose of QP.

DISCUSSION
Recent advances in experimental and computational studies have
shown that, unlike some single drugs of western medicine,
natural medicines or TCM mostly contain multiple components
and exert their therapeutic effects by acting on multiple targets
(Liu Z. et al., 2016; Zhang et al., 2017, 2018). Therefore, it
is necessary to introduce modern technologies and systematic
methods, such as HPLC fingerprint analysis and network
pharmacology, to reveal the pharmacological functions of these
drugs and predict their action mechanisms (Liu Z. et al., 2016;
Zhang et al., 2017, 2018). In this study the HPLC analysis was
used to characterize the phytochemical features of QP ointment
and 3 common peaks were proposed as the fingerprints of its
multiple chemical constituents. According to the fragment ion
at m/z 153 in the mass spectrum indicated that QP contained
major phenolic constituents with the central structural unit of
gallic acid. Previously this type compounds had been showed
treatment effects on ACD or contact dermatitis (Mo et al., 2014;
Fu et al., 2015). However, even though gallic acid, corilagin, and
ellagic acid were identified as major components of QP, there may
be other effective or novel structural compounds in QP since
there are several peaks of HPLC fingerprint analysis. Further
investigation is needed to investigate what they are and whether
they are effective ingredients for the treatment of ACD.
On the other hand, BATMAN-TCM is a bioinformatics
analysis tool developed by our collaborators (Liu Z. et al., 2016;
Zhang et al., 2017). In this study by using BATMAN-TCM,

QP Altered the Levels of Cytokines and
IgE in the Serum or Spleen in SADBE
Mice
By using the IgE, IL-4, IL-5, IL-10, and TNF-α Elisa kits, the
levels of IgE (Figure 8A), IL-4 (Figure 8B), IL-5 (Figure 8C),
IL-10 (Figure 8D), TNF-α (Figure 8E) in the serum and TNF-α
(Figure 8F) in the spleen were detected. Compared with that
in the blank control mice, the production of IgE, IL-5, IL10 and TNF-α in the model group mice were significantly
increased. Positive control drug could significantly reduce IL-4,
IL-5, and IL-10 and TNF-α content in serum, but QP showed
good inhibitory effect in reducing the content of all these
cytokines in the serum or spleen. Among them, the high-dose
of QP showed the most striking effect which significantly to all
markers detected.
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FIGURE 4 | Effect of QP on skin histological changes in SADBE mice. (A) The midline dorsal neck skin images of each group of mice were showed on day 13. The
neck skin lesions in QP treatment groups were fewer than those in the model group. (B,C) showed representative HE staining images and measured skin thickness
of each group as labeled, respectively. (D,E) showed representative toluidine blue images and cell counts of each group as labeled, respectively. Data was
expressed as mean ± SEM. ++++p < 0.0001, compared to the blank group. One-way ANOVA (n = 5 each group). Scale bar: 50 µm.

Our experimental results highlighted the key role of several
Th1/2 cytokines for QP to treat the chronic itch. T helper (Th)
cells have been defined into different subsets by different cytokine
profiles secreted. For example, Th1 cells are characterized by
the secretion of IL-2, IFN-γ and TNF-α, etc., while Th2 cells
secrete IL-4, IL-5, and IL-13, etc (Raphael et al., 2015). Th1
cytokines, like TNF-α/TNFR1 signaling, were showed in animal
behavior as required for both acute and chronic itch (Miao
et al., 2018). More strikingly Th2 cytokines have been reported as
highly involving in the inflammation response directly mediating
chronic itch. For example, recent data suggest IL-4, IL-31, and
IL-33 all have their own receptors expressing in both mouse and
human sensory neurons, and these cytokines enhance neuronal
responsiveness to multiple pruritogens (Cevikbas et al., 2014;
Kaesler et al., 2014; Liu B. et al., 2016; Oetjen et al., 2017). Our
data indicate that high level of interleukin IL-5 was detected in
ACD mouse skin, and significantly increased IgE, IL-4, IL-5, IL10 levels in serum, and as wells as elevated TNF-α in both serum
and spleen. On the other hand, QP can significantly decrease
the upregulation of these molecules in the serum, spleen and
skin. In all, these data would not only support some recent
chronic itch progress related to our studies (Zhao et al., 2013;

we analyzed the potential targets of each component of QP,
and generated a current ACD’s disease-related gene database.
Our results suggested that molecules such as IL-8, CXCR4,
JUN, IL-1β, IL-17A, etc., are potential effector molecules or
downstream molecules of QP, and molecules such as TLR4,
STAT1, STAT3, PRKACA, etc., are chronic dermatitis-associated
targets, while IL-4, IL-6, IL-10, TNF, NFκB1, etc., may cover by
both. As far as we know, this study is the first use of modern
methods of network pharmacology to explore the therapeutic
effect of Tibetan medicine on allergic contact dermatitis.
Certainly, this method still has some limitations. For example,
it mainly relies on the continuous updating and improvement
of the relevant online database (Liu Z. et al., 2016; Zhang et al.,
2017). The results given by BATMAN-TCM were suggested to be
combined with the existing literature and research progress, and
the results of animal and cytological experiments were to make
the most appropriate judgment. The mRNA-seq technology can
provide a method for rapidly distinguishing altered mRNA after
drug treatment (Duan et al., 2019), if possible, the mRNA-seq
work for studying transcriptome expression in a QP-treated ACD
mouse model will help to understand and explain the mechanism
of action of QP.

Frontiers in Pharmacology | www.frontiersin.org

8

April 2019 | Volume 10 | Article 354

Gong et al.

Qingpeng Ointment Ameliorates Chronic Itch

FIGURE 5 | The mRNA of IL-5 (A), IL-10 (B), TRPV4 (C), TSLP (D), GRP (E), and MrgprA3 (F) were detected in mouse skin. After mice were treated with different
doses of QP ointment and diphenhydramine, the targeted molecular mRNA levels were measured as well as that in the model group or the blank control group. Data
was expressed as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗∗ p < 0.0001, compared with the model group. + p < 0.05, ++ p < 0.01, and ++++ p < 0.0001,
compared with the blank control group. One-way ANOVA (n = 5 each group).

FIGURE 6 | QP suppressed the phosphorylation of MAPKs in the skin of SADBE mice. Representative western blots images of p-Stats, Stats, p-Akt, Akt, p-Erk,
Erk, p-P38, p38, p-IκBα, IκBα, and Tubulin, respectively (A). Expression of p-Erk (B) and p-P38 (C) but not p-Stat3 (D), p-Akt (E), and p-IκBα (F) in the skin of
SADBE mice was significantly reduced QP compared to that in the model group. Data was expressed as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and
∗∗∗∗ p < 0.0001, compared to the model group. ++++ p < 0.0001, compared to the blank control group. ANOVA (n = 3 each group). The related original western
blot images were showed in Supplementary Figures S3, S4.

Cevikbas et al., 2014; Kaesler et al., 2014; Liu B. et al., 2016; Oetjen
et al., 2017), but also indicated QP can play anti-inflammatory
and antipruritic actions through these molecules in multiple
places (serum, spleen, skin, and DRG).
Over the past 10 years, effects of various itch mediators
expressed by primary sensory neurons and skin cells (like

Frontiers in Pharmacology | www.frontiersin.org

keratinocytes) have been extensively studied. For example,
keratinocytes released thymic stromal lymphopoietin (TSLP)
could activate sensory neurons and immune cells for itch
(Wilson et al., 2013). Several itch specific neuropeptides, like
GRP (Sun and Chen, 2007), somatostatin (Huang et al., 2018),
and specific neurons like MrgprA3+ (Han et al., 2013) and
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FIGURE 7 | The mRNA of TRPV1 (A), TRPA1 (B), GRP (C) and MrgprA3 (D) were detected in mice DRG. After mice were treated with different doses of QP
ointment and diphenhydramine, the targeted molecular mRNA levels were measured as well as that in the model group or the blank control group. Data was
expressed as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, compared to the model group. + p < 0.05 and ++ p < 0.01, compared to the blank control
group. ANOVA (n = 5 each group).

FIGURE 8 | Effect of QP on the levels of different cytokines or IgE in the serum or spleen of SADBE mice. Among them, (A–E) showed the levels of IgE, IL-4, IL-5,
IL-10, and TNF-α in the serum of each group, and (F) showed of TNF-α in the spleen of each group. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, compared to the
model group. ++ p < 0.01, +++ p < 0.001, and ++++ p < 0.0001, compared to the blank control group. ANOVA (n = 5 each group).

Frontiers in Pharmacology | www.frontiersin.org

10

April 2019 | Volume 10 | Article 354

Gong et al.

Qingpeng Ointment Ameliorates Chronic Itch

GRPR+ (Sun et al., 2009) cells have been identified for the itch
signal transmission. TRP channels, especially thermosensitive
TRP channels including TRPV1, A1,V4 etc., receive multimodal
stimuli and required for itch sensations (Liu Z. et al., 2016;
Kittaka and Tominaga, 2017; Zhang et al., 2017). Research studies
including our work proved both TRPA1 and TRPV1 channels
are required for generating spontaneous scratching induced by
SADBE and TRPV4-expressing epithelial and immune cells in the
skin dynamically mediate chronic itch (Liu Z. et al., 2016; Zhang
et al., 2017). In this study, our work demonstrated the mRNA of
TRPV1, TRPA1, GRP, and MrgprA3 were elevated in the SADBE
mice DRG and /or skin, which were significantly decreased by QP
to a different extent.
Signal transduction originating from membrane-bound
Th1/2 cytokine receptors is a complex network that leads
to intracellular gene expression and ultimately regulates
cellular activities. Among them, the mitogen activated protein
kinase (MAPK) (Ayush et al., 2013; Li et al., 2018; Xiao and
Xiao, 2018), the nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-κB) (Xiao and Xiao, 2018), the Janus
kinase (JAK)/signal transducer and activator of transcription
(STAT) (Bechara et al., 2017; Oetjen et al., 2017) have been
intensively studied and strongly implicated with the pathogenesis
of skin diseases and inflammation-controlling interventions.
Our work supported, probably QP works through p-P38
and p-Erk cell signaling pathways in skin (not DRG, see
Supplementary Figures S2, S5) to treat the chronic itch
in ACD mice.
The pathogenesis of chronic skin diseases including ACD
is complicated, including at least skin barrier dysfunctions,
allergy/immunity, and pruritus (Liu Z. et al., 2016; Kittaka
and Tominaga, 2017; Kostner et al., 2017; Zhang et al., 2017;
Hachisuka et al., 2018). Cytokines can be produced by a
wide array of immune cells, including neutrophils, eosinophils,
mast cells, macrophages, and T cells (Liu Z. et al., 2016;
Kittaka and Tominaga, 2017; Kostner et al., 2017; Zhang et al.,
2017; Hachisuka et al., 2018). Therefore, even though we have
some understanding about the possible cytokines, itch-related
molecules, and related intracellular signaling pathways for QP
to work with, the specific subsets of the cell types, what exact
ingredients, and how they function through these cells and
molecular network systems, etc., need to be further clarified.
Future research on experiments in vitro, genetic engineering
animals, etc., may help address these issues.

and network pharmacology studies of QP ointment. By
in-depth animal and molecular analysis, we identified a
number of chronic dermatitis-associated Th1/2 cytokines,
itch mediators, and cellular signaling pathways in the skin,
DRG and serum for QP to treat the inflammation and
chronic itch associated with ACD. Our data clearly suggested,
upon stimulation, cytokines and itch-related mediators are
released from the skin and neuronal tissues, and QP could
effectively work on both the skin and sensory neurons to treat
the chronic itch.
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CONCLUSION

DATA SHEET S1 | Three main compounds of QP (Figure S1). QP suppressed
the phosphorylation of MAPKs in the DRG of SADBE mice (Supplementary
Figure S2). The data of the original western blot images (Supplementary
Figures S3–S5).

Via a HPLC system and a BATMAN-TCM platform, for the
first time we performed detailed HPLC fingerprint analysis

TABLE S1 | The key targets of chronic dermatitis or QP (Sheet 1), and targets
corresponding to key signaling pathways (Sheet 2) based on the platform of
BATMAN-TCM.
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